• Corpus ID: 1295385

Incidence of low bone mineral density and contributing factors in inflammatory bowel disease

@inproceedings{eknIncidenceOL,
  title={Incidence of low bone mineral density and contributing factors in inflammatory bowel disease},
  author={Ayhan Hilmi Çekın and Seyit Uyar}
}
akademik.tgv.org.tr
1 Citations

Tables from this paper

One Citation

Platelet/lymphocyte ratio is an independent predictor for osteoporosis

Higher P/L seems to be a quite simple marker to help predict postmenopausal PMO, as seen in this study, having low levels of Vit-D is crucial for PMO.

References

SHOWING 1-10 OF 15 REFERENCES

Osteoporosis in Patients with Inflammatory Bowel Disease

Mots cles : Malabsorption ; Osteoporose ; Fractures ; Densite osseuse ; Maladies intestinales

[The risk factor for low bone mineral density in patients with inflammatory bowel disease].

Age, disease duration, clinical activity active index, oral steroid therapy, immunosuppressant treatment and serum vitamin D concentration were not found to be correlated with osteoporosis in IBD patients.

Bone density improves with disease remission in patients with inflammatory bowel disease

In patients with ulcerative colitis and Crohn's disease, age-matched BMD is higher with increasing duration of disease remission and induction of remission by azathioprine.

Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn’s disease and ulcerative colitis

There is a difference between Crohn’s disease and ulcerative colitis, and altered bone metabolism in inflammatory bowel disease is found to be a cause for concern.

Longitudinal study of cortical bone loss in patients with inflammatory bowel disease.

The results show increased rates of cortical bone loss in some patients with inflammatory bowel disease and emphasize the need to monitor bone mass in these patients so that prophylactic measures can be instituted.

Effects of weight and body mass index on bone mineral density in men and women: The framingham study

The results suggest that the strong effect of weight on bone mineral density is due to load on weight‐bearing bones in both sexes, and the sex difference is unexplained but may be due to adipose tissue production of estrogen in women after menopause.

Bone mineral density in patients with inflammatory bowel disease: A population‐based prospective two‐year follow‐up study

Evaluating changes in bone mineral density in IBD patients during a 2‐year follow‐up period indicates that disease activity and corticosteriod therapy are involved in bone loss in CD patients.

Reduced bone density in patients with inflammatory bowel disease.

The greater prevalence of reduced hip bone mineral density and the pattern of a selective increase in bone resorption contrasts with that found in other known causes of metabolic bone disease.

Evolution of osteopenia in inflammatory bowel disease

The evolution of BMD suggests that low bone density is associated with the pathogenesis of CD, whereas in UC it seems to be correlated with the side effects of corticosteroid treatment.

Femoral neck osteopenia in patients with inflammatory bowel disease

There is a high prevalence of reduced BMD at the spine and femoral neck in IBD patients, which is more severe in the hip.